Nuvectis Pharma Statistics
Share Statistics
Nuvectis Pharma has 20.89M
shares outstanding. The number of shares has increased by 27.43%
in one year.
Shares Outstanding | 20.89M |
Shares Change (YoY) | 27.43% |
Shares Change (QoQ) | 21.07% |
Owned by Institutions (%) | 7.67% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 871 |
FTD / Avg. Volume | 0.64% |
Short Selling Information
The latest short interest is 2.1M, so 10.06% of the outstanding
shares have been sold short.
Short Interest | 2.1M |
Short % of Shares Out | 10.06% |
Short % of Float | 19.46% |
Short Ratio (days to cover) | 15.36 |
Valuation Ratios
The PE ratio is -4.87 and the forward
PE ratio is -8.79.
Nuvectis Pharma's PEG ratio is
0.22.
PE Ratio | -4.87 |
Forward PE | -8.79 |
PS Ratio | 0 |
Forward PS | 1.6 |
PB Ratio | 9.53 |
P/FCF Ratio | -7.56 |
PEG Ratio | 0.22 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Nuvectis Pharma.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.09,
with a Debt / Equity ratio of 0.
Current Ratio | 2.09 |
Quick Ratio | 2.09 |
Debt / Equity | 0 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | $-1,461,538.46 |
Employee Count | 13 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 37.92% in the
last 52 weeks. The beta is -0.12, so Nuvectis Pharma's
price volatility has been lower than the market average.
Beta | -0.12 |
52-Week Price Change | 37.92% |
50-Day Moving Average | 9.41 |
200-Day Moving Average | 7.27 |
Relative Strength Index (RSI) | 44.39 |
Average Volume (20 Days) | 135,687 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -19.85M |
Net Income | -19M |
EBITDA | -19M |
EBIT | -19M |
Earnings Per Share (EPS) | -1.11 |
Full Income Statement Balance Sheet
The company has 18.53M in cash and 0 in
debt, giving a net cash position of 18.53M.
Cash & Cash Equivalents | 18.53M |
Total Debt | n/a |
Net Cash | n/a |
Retained Earnings | -73.25M |
Total Assets | 30.15M |
Working Capital | 20.95M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -12.25M
and capital expenditures 0, giving a free cash flow of -12.25M.
Operating Cash Flow | -12.25M |
Capital Expenditures | n/a |
Free Cash Flow | -12.25M |
FCF Per Share | -0.72 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |